Definium Therapeutics Inc
NASDAQ:DFTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Definium Therapeutics Inc
NASDAQ:DFTX
|
US |
|
C
|
Charles Schwab Corp
XMUN:SWG
|
US |
|
Geox SpA
OTC:GXSBF
|
IT |
|
Inghams Group Ltd
ASX:ING
|
AU |
|
Biostem Technologies Inc
NASDAQ:BSEM
|
US |
|
Terrain Minerals Ltd
ASX:TMX
|
AU |
|
Bold Ventures Inc
XTSX:BOL
|
CA |
|
C
|
China Rare Earth Holdings Ltd
HKEX:769
|
CN |
|
Zenith Exports Ltd
NSE:ZENITHEXPO
|
IN |
|
Root Inc
NASDAQ:ROOT
|
US |
|
F
|
Fielmann Group AG
DUS:FIE
|
DE |
|
Linike Medical Group Ltd
OTC:LNMG
|
US |
|
E
|
Energy Absolute PCL
SET:EA
|
TH |
|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
US |
|
Innventure Inc
NASDAQ:INV
|
US |
|
N
|
Nousbo Co Ltd
KOSDAQ:332290
|
KR |
|
WSFS Financial Corp
F:WF4
|
US |
|
H
|
Hct Co Ltd
KOSDAQ:072990
|
KR |
|
E
|
Empire Metals Ltd
F:NOGN
|
UK |
|
Bank of China Ltd
HKEX:3988
|
CN |
|
Komori Corp
F:KOI
|
JP |
|
M
|
Mosaic Co
XMUN:02M
|
US |
|
E
|
Elis SA
F:7EL
|
FR |
|
Larsen & Toubro Ltd
NSE:LT
|
IN |
Bankruptcy Probability
Definium Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Definium Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Definium Therapeutics Inc
NASDAQ:DFTX
|
5.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
643.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
357.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
340.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
217.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
192.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
272B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
156.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
129.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Definium Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Definium Therapeutics Inc has total debt of 36.5m USD. This includes both short-term (0 USD) and long-term (36.5m USD) debt.
You can find a full breakdown on its Balance Sheet.